Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Cefuroxime (1000mg) + Sulbactam (500mg) Injection
Therapeutic Category
Antibiotic, Antibacterials
Dosage Form
Injection
Packaging Type
Vial + Water
Packaging
1.5gm
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Cefuzrom S 1.5 Injection is a powerful combination of Cefuroxime (1000mg) and Sulbactam (500mg). Cefuroxime is a broad-spectrum second-generation cephalosporin antibiotic that works by preventing the formation of bacterial cell walls, leading to bacterial death. Sulbactam is a beta-lactamase inhibitor that enhances the effectiveness of Cefuroxime by preventing bacterial enzymes from breaking it down. Together, they provide effective coverage against a wide range of resistant and non-resistant bacterial infections.
It helps in the treatment of severe respiratory tract infections, urinary tract infections, abdominal infections, skin and soft tissue infections, bone and joint infections, and infections following surgeries or trauma.
May cause pain or swelling at the injection site, diarrhea, nausea, vomiting, skin rash, or headache. Rarely, allergic reactions, liver enzyme changes, or blood disorders can occur.
Used in the treatment of moderate to severe bacterial infections including pneumonia, bronchitis, urinary infections, abdominal infections, gynecological infections, and post-operative infections. It is also effective in treating infections caused by beta-lactamase producing organisms.
Should be administered under the supervision of a healthcare professional. Inform your doctor if you have a history of cephalosporin or penicillin allergy, kidney problems, or gastrointestinal diseases. Complete the full prescribed course even if symptoms improve early.
Store in a cool, dry place below 25°C. Protect from light. Once reconstituted, use immediately or as directed by your healthcare provider. Keep out of reach of children.
Composition : Cefuroxime (125mg) + Clavulanic Acid (31.25mg)
Composition : Cefuroxime (125mg)
Composition : Cefuroxime (1.5gm)
Composition : Cefuroxime (1500mg) + Sulbactam (750mg)
Composition : Cefuroxime (250mg)
Composition : Cefuroxime (500mg)
Composition : CEFUROXIME 250 MG + CLAVULANATE 125 MG
Composition : Cefuroxime (500mg) + Clavulanic Acid (125mg)
Composition : Cefepime (2gm) + Tazobactum (250mg) Injection
Composition : Cefepime (1gm) + Sulbactum (500mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Cefuroxime 1000mg + Sulbactam 500mg Injection has consistent demand in the hospital care, general medicine, surgery, gynecology, and anti-infective segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on hospital injectables and antibiotic portfolios.
Medical distributors and agencies can benefit from consistent demand for management of susceptible bacterial infections under medical supervision. Cefuroxime 1000mg is a second-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis and is effective against a broad range of susceptible Gram-positive and Gram-negative bacteria Sulbactam 500mg is a beta-lactamase inhibitor that enhances the antibacterial activity of cefuroxime by protecting it from degradation by certain beta-lactamase-producing organisms This combination is commonly prescribed for the treatment of respiratory tract infections, urinary tract infections (UTIs), skin and soft tissue infections, gynecological infections, bone and joint infections, intra-abdominal infections, and postoperative or surgical infections, as advised by healthcare professionals Administered by intravenous or intramuscular injection, with dosage individualized according to the patient's age, body weight, renal function, and severity of infection Should be used only for suspected or confirmed susceptible bacterial infections to promote responsible antibiotic use and reduce the development of antimicrobial resistance. Patients should be monitored for allergic reactions and other adverse effects during therapy Frequently utilized in hospitals, emergency departments, surgical units, intensive care units (ICUs), and community healthcare settings Widely prescribed by physicians, surgeons, gynecologists, orthopedicians, and infectious disease specialists for appropriate bacterial infections This strengthens a comprehensive hospital injectable and anti-infective portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Cefuroxime 1000mg + Sulbactam 500mg Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from consistent hospital and institutional demand, strong anti-infective market opportunities, reliable supply chain support, repeat procurement, government and private hospital business, and attractive margins in the injectable antibiotic segment.
Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality hospital injectable and anti-infective products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.